L-carnitine Supplementation in Rheumatoid Arthritis Patients

This study investigates whether L-carnitine supplementation — a naturally occurring nutrient involved in energy metabolism — can reduce inflammation and improve outcomes in people with active rheumatoid arthritis (RA) who are already on standard disease-modifying drugs. **You may be eligible if...** - You are 18–60 years old - You have been diagnosed with rheumatoid arthritis for at least 6 months - You are currently on conventional RA drugs (DMARDs) at a stable dose for at least 1 month, but your disease is still active **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have liver or kidney dysfunction above specified levels - You have an active infection or concurrent cancer - You have other uncontrolled medical conditions or other rheumatic diseases - You are taking warfarin (a blood thinner) or other drugs that interact with carnitine Talk to your doctor to see if this trial is right for you.